Cargando…

SARS-CoV-2: a potential novel etiology of fulminant myocarditis

Detalles Bibliográficos
Autores principales:	Chen, Chen, Zhou, Yiwu, Wang, Dao Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Medizin 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080076/ https://www.ncbi.nlm.nih.gov/pubmed/32140732 http://dx.doi.org/10.1007/s00059-020-04909-z

Ejemplares similares

Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection()
por: Lozano Gómez, Herminia, et al.
Publicado: (2020)

SARS-CoV-2 Fulminant Myocarditis
por: Garot, Jérôme, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Fulminant myocarditis as an early presentation of SARS-CoV-2
por: Naneishvili, Tamara, et al.
Publicado: (2020)

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes
por: Hang, Weijian, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Potentially irreversible olfactory and gustatory impairments in COVID-19: Indolent vs. fulminant SARS-CoV-2 neuroinfection
por: Vavougios, George D.
Publicado: (2020)

Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection
por: Beuy, Joob, et al.
Publicado: (2019)

Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Wiwanitkit, Viroj
Publicado: (2020)

Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO
por: Bhardwaj, Abhishek, et al.
Publicado: (2022)

Myocarditis in the era of SARS-CoV-2: one piece of a complex puzzle?
por: Polito, Maria Vincenza, et al.
Publicado: (2020)

SARS-CoV-2 associated polyradiculitis and myocarditis may favour Takotsubo syndrome
por: Finsterer, Josef, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for unexpected death from atrial myocarditis: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient
por: Ghafoor, Khuzema, et al.
Publicado: (2021)

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022)

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022)

Perimyocardial Injury Specific for SARS-CoV-2-Induced Myocarditis in Comparison With Non-COVID-19 Myocarditis: A Multicenter CMR Study
por: Haberka, Maciej, et al.
Publicado: (2022)

Author's Reply to Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Kim, In-Cheol, et al.
Publicado: (2020)

Plasma Siglec-5 and CD163 as Novel Biomarkers for Fulminant Myocarditis
por: Zhuang, Yan, et al.
Publicado: (2022)

Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination
por: Vogrig, Alberto, et al.
Publicado: (2023)

The first succesful extracorporeal membranous oxygenation treatment in a child with refractory fulminant myocarditis in Turkey
por: Anıl, Ayşe Berna, et al.
Publicado: (2016)

Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
por: Dai, Mei-Yan, et al.
Publicado: (2023)

Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021)

Before blaming SARS-CoV-2 vaccination for unexpected death from atrial myocarditis, rule out alternative pathophysiologies
por: Finsterer, Josef
Publicado: (2023)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

To: Fulminant myocarditis associated with the H1N1 influenza virus: case report and literature review
por: Joob, Beuy, et al.
Publicado: (2015)

Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir
por: Koenig, Tobias, et al.
Publicado: (2021)

International Expansion of a Novel SARS-CoV-2 Mutant
por: Wang, Minjin, et al.
Publicado: (2020)

SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study
por: Gauchotte, Guillaume, et al.
Publicado: (2021)

Commentary on: “Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination” by C. Schwab et al.
por: de Boer, Hans H., et al.
Publicado: (2023)

Incidence of myocarditis and pericarditis considered as separate clinical events over the years and post-SARS-CoV2 vaccination in adults and children
por: Conte, Edoardo, et al.
Publicado: (2023)

Potential drawbacks of SARS-CoV-2 seroprevalence surveys
por: Lippi, G.
Publicado: (2021)

Cardiac mobile thrombi formation in an unvaccinated young man with SARS-CoV-2 associated fulminant eosinophilic myocarditis
por: Yalcinkaya, Damla, et al.
Publicado: (2022)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

Letter to the Editors: “Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination” by C. Schwab et al.
por: Schirmacher, Peter, et al.
Publicado: (2023)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Fulminant Encephalitis Caused by SARS-CoV-2 in a Two-Month-Old Infant
por: Abdelbari, Marwa, et al.
Publicado: (2022)

Only blame SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out
por: Finsterer, Josef, et al.
Publicado: (2023)

FULMINANT MYOCARDITIS, A RARE CASE ASSOCIATED WITH SARS-COV-2 INFECTION
por: Nadkarni, Anish, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gftadq0vn2jvp2rm6ekv4gg8sh